Read next
Pharmaceutical Supply Chains Expand API Capacity for Metabolic Drugs
Active pharmaceutical ingredient manufacturers invest in continuous manufacturing to resolve global GLP-1 shortages.
Clinical Trials Highlight Efficacy of Next-Generation Targeted RNA Therapeutics
Phase II trial results reveal high organ specificity for novel lipid nanoparticle delivery platforms, expanding treatment avenues for…
GLP-1 Receptor Agonists Reshape Commercial Food and Healthcare Sector Valuations
Widespread adoption of anti-obesity medications is influencing consumer purchasing behavior and altering long-term forecasts for chronic disease management.
Cholesterol: What the Numbers Mean
Not one number but several, and the relationships between them matter more than any single value.
Healthcare Systems Integrate Targeted AI Models to Reduce Administrative Radiologist Burden
Hospital networks are deploying domain-specific machine learning models to automate triaging and lower diagnostic report backlog times.
AI-Driven Biomarker Discovery Accelerates Phase II Clinical Trials
Pharmaceutical firms report reduced attrition rates in early-stage oncology trials by deploying machine learning models for patient stratification.